On the other hand, the majority of studies in literature have investigated serum concentrations of MMP-2 and MMP-9 and showed a higher concentration of these serum proteins in breast cancer patients than in women with fibroadenoma, corroborating data of immunohistochemical expression [15, 16, 25]. This evidence concerns the gene MMP9 and Fibroadenoma.